皇家华人

header-logo
GettyImages-609179959-hero
headshot

Mehdi H. Hamadani, MD

Professor

view physician profile

Locations

  • Froedtert Hospital
  • Cancer Center - Froedtert Hospital
  • Cancer Center - Moorland Reserve Health Center

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English, Urdu, Hindi, Punjabi

Cancer Center - Froedtert Hospital

Moorland Reserve Health Center

Education

  • MD - Doctor of Medicine

Biography

Mehdi Hamadani, MD, is A a professor of medicine at the 皇家华人, Division of Hematology & Oncology, specializing in lymphoma, and bone marrow transplantation. Dr. Hamadani serves as the Director of the Adult Blood and Marrow Transplant Program (BMT) at Froedtert Hospital. He graduated from King Edward Medical College (with honors) in Pakistan in 2001, he then completed his internal medicine residency at Oklahoma University Health Sciences Center and a Fellowship in Hematology and Oncology at The Ohio State University. He received the James V. Warren Award for Accomplishments as The Most Outstanding Research Fellow, during his fellowship.

Research Interests

Dr. Hamadani has authored over 200 peer-reviewed publications, and has been invited as a speaker for several national and international meetings. He is the recipient of Conquer Cancer Foundation of ASCO Career Development Award and ASBMT New Investigator Award. Dr. Hamadani has also received several Best Attending Physician, Outstanding Teacher, Press Ganey Top Provider and Best Doctors in America Awards. His clinical research focuses on lymphoid malignancies and hematopoietic cell transplantation. Dr. Hamadani is board certified in Hematology and Medical Oncology.

Publications

  • (Yohay S, Oloyede T, Kim S, Fang X, Dhakal B, Aijaz A, Mohan M, Narra R, Pasquini M, D'Souza A, Hamadani M, Freeman CL, Akhtar OS.) Br J Haematol. 2024 Dec;205(6):2370-2375 PMID: 39396814 SCOPUS ID: 2-s2.0-85206072300 10/14/2024

  • (Akhtar OS, Arshad S, Lian Q, Ahn KW, D'Souza A, Dhakal B, Mohan M, Pasquini M, Longo W, Shah NN, Fenske TS, Hamadani M.) Transplant Cell Ther. 2024 Dec;30(12):1191.e1-1191.e8 PMID: 39303985 SCOPUS ID: 2-s2.0-85206435293 09/21/2024

  • (Levis MJ, Hamadani M, Horowitz MM, Chen YB, BMT CTN 1506 Investigators.) J Clin Oncol. 2024 Nov 10;42(32):3881-3882 PMID: 39083722 PMCID: PMC11540746 SCOPUS ID: 2-s2.0-85201082528 07/31/2024

  • (Pophali PA, Fein JA, Ahn KW, Allbee-Johnson M, Ahmed N, Awan FT, Farhan S, Grover NS, Hilal T, Iqbal M, Maakaron J, Modi D, Nasrollahi E, Schachter LG, Sauter C, Hamadani M, Herrera A, Shouval R, Shadman M.) Blood Adv. 2024 Oct 22;8(20):5290-5296 PMID: 38985302 PMCID: PMC11497379 07/10/2024

  • (Khaliq A, Wesson W, Logan E, Tabak C, Mushtaq MU, Lin T, Baranda J, Shune L, Abdallah AO, McGuirk J, Hamadani M, Ahmed N.) Clin Lymphoma Myeloma Leuk. 2024 Oct;24(10):e344-e349 PMID: 38910060 06/24/2024

  • (Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, Hamadani M, Arai S, Salhotra A, Perez-Simon JA, Alousi A, Choe H, Kwon M, Bermúdez A, Kim I, Socié G, Chhabra S, Radojcic V, O'Toole T, Tian C, Ordentlich P, DeFilipp Z, Kitko CL, AGAVE-201 Investigators.) N Engl J Med. 2024 Sep 19;391(11):1002-1014 PMID: 39292927 09/18/2024

  • (Mercadal S, Ahn KW, Allbee-Johnson M, Ganguly S, Geethakumari PR, Hong S, Malone A, Murthy H, Pawarode A, Sica AR, Solh M, Ustun C, Shadman M, Sauter CS, Hamadani M, Herrera AF, Lee CJ.) Haematologica. 2024 Sep 05 PMID: 39234871 09/05/2024

  • (Iqbal M, Kumar A, Dreger P, Chavez J, Sauter CS, Sureda AM, Bachanova V, Maziarz RT, Dreyling M, Smith SM, Jacobson C, Glass B, Casulo C, Oluwole OO, Montoto S, Advani R, Cohen J, Salles G, Hamad N, Kuruvilla J, Kahl BS, Shadman M, Kanate AS, Budde LE, Kamdar M, Flowers C, Hamadani M, Kharfan-Dabaja MA.) Transplant Cell Ther. 2024 Sep;30(9):832-843 PMID: 38972511 07/08/2024

  • (Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE.) Transplant Cell Ther. 2024 Sep;30(9):917.e1-917.e12 PMID: 38944153 PMCID: PMC11587342 SCOPUS ID: 2-s2.0-85199289175 06/30/2024

  • (Kim NH, Hamadani M, Abedin S.) Expert Opin Investig Drugs. 2024 Aug;33(8):791-799 PMID: 38973782 PMCID: PMC11305901 SCOPUS ID: 2-s2.0-85198098956 07/08/2024

  • (Shadman M, Ahn KW, Kaur M, Lekakis L, Beitinjaneh A, Iqbal M, Ahmed N, Hill B, Hossain NM, Riedell P, Gopal AK, Grover N, Frigault M, Brammer J, Ghosh N, Merryman R, Lazaryan A, Ram R, Hertzberg M, Savani B, Awan F, Khimani F, Ahmed S, Kenkre VP, Ulrickson M, Shah N, Kharfan-Dabaja MA, Herrera A, Sauter C, Hamadani M.) Blood Cancer J. 2024 Jul 08;14(1):108 PMID: 38977682 PMCID: PMC11231252 SCOPUS ID: 2-s2.0-85197736867 07/09/2024

  • (Hansen DK, Dhakal B, Hamadani M, Dingli D, Jain T, Huff CA, Janakiram M, Liu YH, De Braganca KC, Lodowski N, Sander J, Okorozo P, McFarland L, Perciavalle M, Huo S, Qureshi ZP, Patel KK.) Front Immunol. 2024;15:1405452 PMID: 38915401 PMCID: PMC11194690 SCOPUS ID: 2-s2.0-85196643451 06/25/2024

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.